Q&A: GSK vaccine leader Judy Stewart navigates vaccination slumps, always-on marketing and innovating data tools
It’s been a tough couple of years for traditional vaccine makers. While the Covid-19 pandemic spurred a flurry of innovation and turned a white-hot spotlight on the footrace for Covid vaccine approvals, routine vaccination rates plummeted.
Early restrictions, ongoing health precautions and supply chain issues caused millions of people to skip recommended vaccines by the end of 2021. The World Health Organization recently reported that 2021 suffered “the largest sustained decline in childhood vaccinations” in 30 years.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.